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Astract: 
This review aimed to examine strategies applied in interventions to prevent image and 
performance enhancing drug use in the context of intervention effectiveness. Comprehensive 
searches identified 14 interventions that met review inclusion criteria. Interventions were 
predominantly educational and delivered within school sport settings, but targeted a wide 
range of mediating factors. Identification of effective components was limited across studies 
by brief or imprecise descriptions of intervention content, lack of behavioural outcome 
measures and short-term follow up times; however studies with components in addition to 
information provision may be more promising. Interventions are required outside of sport 
settings to reflect the transition of this form of substance use to the general population. 
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Introduction 
Anabolic steroids 
Anabolic steroids (AS) are the most prominent of a range of substances used to modify 
appearance and performance known as image and performance enhancing drugs (IPEDs). 
Globally the lifetime prevalence of AS has been estimated at 3.3%, with higher prevalence 
amongst males (6.4%) (Sagoe et al., 2014b), and it is suggested that nearly one third of AS 
users will develop a form of dependence (Pope et al., 2014a). Although AS can be used without 
adverse consequences, such as when used therapeutically, risk of harm increases with the far 
greater doses observed when AS are used outside of clinical settings (Harmer, 2010). 
Additionally, the quality of illicitly produced AS cannot be controlled and those using them 
frequently do so as part of complex IPED regimens. This misuse of AS is associated with a 
range of acute and chronic adverse consequences (Pope et al., 2014b) that range greatly from 
cosmetic (e.g. acne) to critical (e.g. cardiovascular disease, liver function) with evidence of 
potential psychological harms (e.g. increased aggression, mania) (ACMD, 2010b). Harms 
appear to increase with long-term use, which may be characterised by polypharmacy, long or 
continuous cycles of use, body image disturbance and obsession with training and diet 
(Kanayama et al., 2009). 
The majority of those using AS inject their drugs and are exposed to risks such as injection site 
injury, infection and blood-borne viruses (BBV)(ACMD, 2010b). In the UK, HIV prevalence 
amongst IPED users has been identified as similar to those who inject psychoactive drugs 
(Hope et al., 2013) and there is evidence of risky sexual behaviour (Hope et al., 2013; Bates 
and McVeigh, 2016) and sharing of injection equipment (ACMD, 2010a) that highlights the 
possibility of BBV transmission within and beyond this population. In sport the harms of drug 
use to competition itself and to the sense of fair play has long been a topic of debate (Fraleigh, 
1984; Todd, 1987). Use of AS and other IPEDs are prohibited in accordance with the World 
Anti-Doping Agency’s Prohibited List (WADA, 2017) with consequences to athletes from 
using banned substances including lengthy bans from competition which impacts upon 
reputations, careers and future earnings. 
That interventions to prevent use of AS are required has long been recognised (Council on 
Scientific Affairs, 1988; Nutter, 1993). Historically, use of these substances has been most 
strongly associated with ‘doping’ to enhance sporting performance amongst athletes and 
concerns over use in sports continues. However, misuse amongst the wider population has been 
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reported since the 1980s (Buckley et al., 1988; Johnson et al., 1989) and evidence suggests that 
globally the use of AS is increasingly widespread outside of sports environments (Sagoe et al., 
2014b; Pope et al., 2014a; McVeigh and Begley, 2016). Participation in sport may not be the 
primary risk factor for AS use (Harmer, 2010) and outside of sport common motivations 
include supporting an attractive and healthy physique and enhancing muscle growth and 
physical strength (Sagoe et al., 2014a; Brennan et al., 2016). Further, use of AS in some 
individuals has been associated with body image disorders such as muscle dysmorphia and 
high drive for muscularity (Kanayama et al., 2006; Rohman, 2009). Interventions are therefore 
required to prevent use of these substances amongst a range of populations.  
Behaviour change interventions 
Interventions that aim to change behaviour are likely to be complex. In order to develop 
effective interventions, it is therefore necessary to understand which intervention components 
work, or do not work. Over the past decade developments in the field of behaviour change 
science support researchers to unpick interventions and to systematically examine intervention 
components (Michie and Prestwich, 2010; Michie et al., 2013; Michie et al., 2011). For 
interventions to be effective, appropriate behaviour change mechanisms must be identified and 
the application of theory in their development is recommended to guide this (Craig et al., 2008). 
Examining the components and the application of theory in interventions provides insight into 
the nature of these interventions and it may be possible to identify approaches that are likely to 
be effective or ineffective. 
Review aims   
While useful summaries of the evidence base exist, previous examinations of prevention 
approaches (Backhouse et al., 2014; Bahrke, 2012) have not examined the content of AS 
prevention efforts. Additionally, there are a number of recent evaluations of relevant 
interventions that require consideration. This review therefore aimed to systematically identify 
the behaviour change strategies applied in interventions that have sought to prevent the misuse 
of drugs to enhance muscularity, performance or appearance. This included the characteristics 
and components of interventions and their settings and target populations, and the utilisation 
of theory in intervention development, delivery and evaluation. Additionally the review aimed 
to identify whether particular behaviour change strategies are associated with reducing use of 
these drugs.  
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Methods 
Development and reporting of the review was guided by the statement of Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) (Moher et al., 2009). The review 
followed methods described in the review protocol registered on the PROSPERO International 
Register of Systematic Review (ID CRD42016051204).  
Search strategy  
A comprehensive search for relevant studies was undertaken in December 2016 in the 
following databases: the Cochrane Library, MEDLINE, PsycINFO, Sports Discus, the Social 
Science Citation Index and Conference Proceedings Citation Index. Search strategies were 
developed based on combinations of free text and controlled vocabulary terms adapted to each 
database but included variations of: anabolic steroid, performance enhancing, doping, muscle 
enhancing, IPED, PIED, PED, sport, athletes, gym, fitness, school, bodybuilding, weight 
training and prison. A full sample search strategy is available in the online supplementary 
material and from the authors. The publication lists of organisations including the Advisory 
Council on the Misuse of Drugs, US Anti-Doping Agency, UK Anti-Doping, Druginfo and the 
US National Institute on Drug Abuse, and of key literature reviews relevant to this review 
(Backhouse et al., 2014; Petróczi et al., 2014; Bahrke, 2012) were reviewed. 
Inclusion criteria and study selection 
Studies published from 1990-2016 were eligible for inclusion to include the time period since 
early calls for AS prevention interventions (Council on Scientific Affairs, 1988; Nutter, 1993). 
Inclusion criteria were controlled studies of interventions published in English or French that 
aimed to prevent misuse of drugs taken to enhance muscularity, performance or appearance. 
This included studies focussing on the use of specific drugs such as AS, but also studies that 
applied broader terms to the substances they focussed on such as prevention of ‘performance 
enhancing drugs’, or ‘doping’. These terms are strongly associated with AS, but can also 
include other drugs used alone or alongside AS, so are referred to here under the umbrella of 
IPEDs. Universal interventions and those targeted to any populations including, but not 
restricted to, young people, gym users, bodybuilders, athletes and men who have sex with men 
were eligible for inclusion. Studies were included where an intervention was compared with 
no intervention or a control intervention, and outcomes relating to the use of IPEDs or 
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intentions, attitudes, norms or knowledge relating to IPED use, were reported. One reviewer 
screened titles and abstracts of identified articles, with a sample of 10% screened independently 
by a second reviewer to determine eligibility for inclusion against pre-determined criteria. The 
full text of articles included at this stage were downloaded and screened for eligibility in the 
same way. Reviewer agreement on inclusion and exclusion was 100%.  
Data extraction and quality assessment 
The methodological quality of studies was assessed using criteria set out in the Effective Public 
Health Practice Project (EPHPP) quality assessment tool (Thomas et al., 2004). This tool is 
appropriate to use in systematic reviews of effectiveness interventions (Deeks et al., 2003) 
evaluated using a range of methodologies (Jackson and Waters, 2005). Study strengths and 
weaknesses were considered alongside discussion of study findings. The data extraction 
process was developed to gather as much information as possible on the nature of interventions. 
Data relating to study design, population and methodology, intervention characteristics, study 
outcomes and process outcomes were extracted using a form in Microsoft Access designed for 
this review. Two reviewers undertook study quality and data extraction independently. 
Discrepancies at all stages were resolved through discussion.  
Identification of behaviour change strategies 
The theoretical basis of interventions were examined using the coding scheme developed by 
Michie and Prestwich (Michie and Prestwich, 2010) designed to identify the extent to which 
theory is used in the development, implementation and evaluation of interventions. Behaviour 
change techniques (BCTs) were grouped according to the revised Behaviour Change 
Technique Taxonomy (Michie et al., 2013), a hierarchically structured taxonomy of 93 BCTs. 
BCTs are defined as the smallest components of an intervention and were recorded when 
explicitly reported by article authors (Behaviour Change Technique Taxonomy v1). The 
Taxonomy has been applied in systematic reviews to identify BCTs associated with effective 
approaches designed to influence a variety of behaviours including obesity management, 
physical activity, sexual health, alcohol use and cardiac rehabilitation (Martin et al., 2013; 
Burns et al., 2016; Heron et al., 2016; Prestwich et al., 2016; Bird et al., 2013). To help 
understand behaviour change strategies the Behaviour Change Wheel (Michie et al., 2011) 
was used to identify the behaviour change function(s) in each intervention. The tool includes 
nine distinct functions that interventions can perform in order to change behaviour 
(education, persuasion, incentivisation, coercion, training, restriction, environmental 
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restructuring, modelling and enablement). Where further information on intervention content 
was required, authors of studies published since 2000 were contacted. Five of six authors 
contacted responded with additional information not included in published articles. Initially, 
two reviewers independently applied the Taxonomy, Behaviour Change Wheel and theory coding 
scheme to all identified interventions to identify BCTs, intervention functions and theoretical 
background. There was agreement between reviewers on 10/14 interventions for BCTs, on 12/14 
interventions for intervention functions and 12/14 interventions for theoretical background. 
Findings were then compared and all disagreements were resolved through discussion between the 
two reviewers. 
Analysis 
Results relating to identification of behaviour change approaches, theoretical constructs and 
behaviour change techniques are presented in structured tables and as a narrative summary. 
Findings relating to intervention effectiveness on relevant outcomes are summarised in tables. 
For the outcome of intervention impact on IPED use, effect sizes are reported and where not 
available in articles these were calculated where possible. Due to a combination of factors 
including variation between studies in design, intervention approach and outcome measures, 
meta-analysis was not appropriate to examine intervention effectiveness. 
Results 
After deduplication 12,857 articles were identified through database and supplementary 
searches. The study selection process is summarised in Figure 1, with 23 articles eligible for 
inclusion in the review. These 23 articles covered 17 studies that evaluated 14 distinct 
interventions (two interventions were evaluated at pilot and full study stage, and one 
intervention was trialled and evaluated with two populations). 
[Insert figure 1 here] 
Summary of identified studies 
The characteristics of the 14 interventions are summarised in Table 1. The interventions were 
predominantly delivered in educational settings to young athletes and sought to influence 
behaviour by providing messages about IPEDs and associated harms. A range of other 
approaches were applied usually alongside IPED education including the development of skills 
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and knowledge to encourage healthy alternatives to IPED use, wider health promotion, 
changing of appearance norms, the development of positive morals and values, and drug testing. 
Only 2 of 14 interventions were delivered outside of educational settings, one that targeted 
adolescents in the community (Nilsson et al., 2004; Nilsson et al., 2001) and one that targeted 
adolescent and adult gym users (Jalilian et al., 2011). Further details on intervention 
characteristics and delivery are provided in the online supplemental material and are available 
from the authors. 
[Insert Table 1 here] 
In 11 of 14 interventions, the primary aim was to reduce risk factors for IPED use. In addition, 
ATHENA (Elliot et al., 2004) was a health promotion intervention aiming to reduce disordered 
eating and IPED use; and a university-based drug education programme (Tricker and Connolly, 
1996) and the SATURN programme (Goldberg et al., 2003; Goldberg et al., 2007) aimed to 
reduce substance use (including IPEDs) amongst student athletes. The ATHENA and ATLAS 
programmes were evaluated at short- and long-term follow up (two and one years respectively) 
and the German anti-doping intervention (Wippert and Fließer, 2016) was evaluated up to two 
years following the intervention. All other studies included follow up at 3 months following 
intervention completion or less.  
Summary of study quality 
Overall ratings of study quality are presented in Table 1 with full details of the quality 
assessment available in the online supplementary materials and from the authors. Overall three 
studies were rated strong, five studies were rated moderate and nine studies were rated weak 
using the EPHPP tool. Across the studies, common areas of weakness were withdrawals and 
drop outs, particularly across studies that recruited from school sports teams; and potential for 
selection bias. Further, in seven studies important differences between groups identified at 
baseline measurements were not reported or addressed. Amongst nine studies that reported 
random allocation to groups, in only one study was the method of randomisation described 
(Elliot et al., 2004). 
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Behaviour change strategies 
Five of the nine intervention functions in the Behaviour Change Wheel (Michie et al., 2011) 
were identified across the studies in different combinations, presented in Appendix 1. These 
interventions applied predominantly educational strategies to influence IPED use and risk 
factors. The most frequently identified functions were education (12 of 14 interventions), 
persuasion (7 of 14 interventions) and training (5 of 14 interventions) in different combinations. 
Training elements of interventions included information about weight training techniques (n=4) 
and skills to resist IPEDs (n=3). Two interventions included exercise sessions where weight 
lifting techniques were demonstrated and practiced in addition to an educational programme 
(Goldberg et al., 1996b; Goldberg et al., 1996a; Sagoe et al., 2016).  
Across the interventions 18 BCTs were identified (range 1 to 7), applied in many different 
combinations as presented in Table 2. Identification of BCTs was often difficult due to brief 
and imprecise reporting of interventions. Therefore it is possible that further BCTs were 
applied that could not be verified here. The most frequently identified BCTs involved 
information provision (‘Information on social and environmental consequences’, n=9; 
‘Information about health consequences’, n=8), followed by ‘Instruction on how to perform 
the behaviour’ (n=5), reflecting the educational function of interventions identified. Smaller 
numbers of studies additionally included BCTs to influence social norms (such as the use of 
credible sources to deliver talks, information about others’ perceptions about AS use) or self-
regulating behaviour (such as goal setting, and self-monitoring). Most studies included 
between two and four BCTs, with more than four BCTs identified in only the ATLAS 
(Goldberg et al., 1996b; Goldberg et al., 1996a) and ATHENA (Elliot et al., 2004) programmes.  
[Insert Table 2 here] 
Interventions with multiple intervention functions and those that included higher numbers of 
BCTs tended to be associated with more encouraging results. More promising studies appeared 
likely to include a combination of education through information provision about IPEDs with 
components designed to develop skills, change social norms, or encourage goal setting. Two 
interventions associated with reductions in IPED use (Elliot et al., 2004; Nilsson et al., 2004) 
were the only interventions where participants received information on other people’s 
perceptions about healthy behaviours (‘Information about others’ approval’). Interventions 
associated with increases in undesirable attitudes (Elbe and Brand, 2016; Goldberg et al., 2003; 
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Goldberg et al., 2007) and perceived norms (Goldberg et al., 2003; Goldberg et al., 2007) were 
studies for which just one BCT was identified, and were not educational. 
The theory coding tool (Michie and Prestwich, 2010) was applied to all papers. Generally 
theoretical constructs were poorly reported. The theoretical bases of six interventions were 
identified with specific theories including ethical reasoning theory (Elbe and Brand, 2016), the 
theory of planned behaviour (TPB) (Jalilian et al., 2011), social learning theory (SLT) 
(Goldberg et al., 1996b; Goldberg et al., 1996a) and a combination of SLT and the health belief 
model (Sagoe et al., 2016). In the mediation analysis of ATHENA, models of behaviour 
including the TPB, social cognitive theory and the information, motivation, behaviour model 
were described (Ranby et al., 2009). Although no specific theories were described, the Greek 
anti-doping education intervention (Barkoukis et al., 2016) was based upon establishing social 
norms and sporting values. For all other studies no theoretical bases were described, and it was 
therefore not possible to determine whether relevant constructs were used in the development 
or evaluation of interventions. The rationale or theoretical bases for control groups were not 
described in any study. 
There was evidence for the six studies where a theoretical basis was identified that theory had 
been used to develop intervention techniques. All six studies measured theory relevant 
constructs at evaluation, and in four studies (Goldberg et al., 1996b; Sagoe et al., 2016; Jalilian 
et al., 2011; Barkoukis et al., 2016) outcomes were discussed, to at least some extent, in relation 
to theory. The ATLAS intervention had the most explicit links between theory and intervention 
development and evaluation, and mediation analysis further explored theoretical constructs 
underpinning the intervention (MacKinnon et al., 2001). 
Intervention effectiveness 
Evaluations of 5/15 interventions measured changes in IPED use, summarised in Appendix 2. 
Potential to reduce use was limited by low numbers of users at baseline and short-term follow-
ups and, although positive intervention effects on IPED use were reported, effect sizes (where 
available) were small. Evaluation of the only intervention targeting adults alongside 
adolescents in a gym reported a reduction in AS use, but findings were limited by small sample 
size and short-term follow up (Jalilian et al., 2011). Evaluation of a community wide 
programme indicated that use of AS may have reduced slightly (Nilsson et al., 2004), but 
findings were limited by the cross-sectional study design. There were also indications that the 
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ATLAS and ATHENA interventions had positive impacts on IPED use. Short-term evaluation 
of ATHENA (Elliot et al., 2004) indicated fewer new users of ‘body shaping drugs’ amongst 
girls who received the intervention. However, this measure included supplements as well as 
AS, and there was no effect of the intervention on the similar long-term outcome of ‘steroid 
and creatine use’ (Ranby et al., 2009). Use of AS increased slightly following the ATLAS 
intervention, but at a lower rate than amongst controls (Goldberg et al., 1996b). Numbers 
reporting AS use were low throughout the evaluation however and the differences between 
groups were not statistically significant.  
Evaluation of the pilot study of random drug testing in a small sample of school athletes was 
suggested to have had a positive impact upon past month IPED use (Goldberg et al., 2003). 
However, there was no impact on new users and evaluation of the pilot and follow up studies 
suggested risk factors increased (Goldberg et al., 2003; Goldberg et al., 2007). Across studies 
other outcomes commonly assessed included intentions to use IPEDs, and a range of measures 
of attitudes, knowledge and subjective norms (summarised in Table 1). Knowledge of IPEDs 
was generally improved following interventions, however impact was less clear on intentions, 
attitudes and subjective norms with small changes in the desired direction on some measures. 
Intervention fidelity in delivery 
Evaluation of ATHENA identified that, on average, teams included 81% of intended 
intervention content in each session (Elliot et al., 2004). In no other studies was any indication 
of intervention fidelity reported. As such, it was not possible to determine whether 
interventions were delivered or received in the intended manner, or using the BCTs and 
strategies identified.  
Discussion 
This review examines the nature and findings of interventions that have sought to prevent or 
reduce use of AS and other IPEDs over more than two decades. In 1996 the authors of one of 
these interventions noted that in comparison to other substances, there had been little research 
into AS prevention (Goldberg et al., 1996a). Over twenty years later, during which time 
prevalence in the general population has greatly increased (Pope et al., 2014a) and a substantial 
amount of research examining the topic has taken place (McVeigh and Begley, 2016), the 
findings of this review suggest that this statement still holds true. While there is a growing 
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body of evidence relating to AS regarding aetiology, epidemiology and related harms, it would 
appear that little is known on how to influence behaviour change, particularly outside of 
sporting environments. Interventions have been tested that attempt to induce change in AS or 
other IPED use through targeting many different behavioural risk and protective factors, such 
as  focussing on ethics and values, harms, healthy alternatives, body image and social norms. 
Since the studies in the 1990s by Goldberg and colleagues, these interventions do not generally 
appear to have built upon what has preceded them and the evidence therefore largely consists 
of a series of ‘one off’ interventions that vary greatly in focus. There is no indication of the 
coherent development of a body of evidence since the first studies investigating AS prevention, 
and consequently there are no clear messages emerging on what approaches are likely to be 
effective or ineffective. 
Interventions in this area have focussed predominantly on young athletes. There remains a need 
to develop effective interventions to respond to the use of AS in both professional and amateur 
sport, and the lack of studies evaluating interventions in these environments outside of schools 
suggests that any current approaches need to be evaluated using robust study designs. The 
evidence regarding prevention outside of the sporting domain is severely lacking. Interventions 
are required in response to increasing use of drugs, particularly AS, to enhance muscularity 
and appearance for non-sporting reasons, which are associated with a range of physical and 
psychological harms (Pope et al., 2014b; Hope et al., 2013; ACMD, 2010b). These 
interventions will likely require different strategies than those targeting athletes hoping to 
improve sporting performance and therefore the strategies applied within school sport settings 
may not be transferable to the wider population. For example, recent interventions that focus 
on influencing ethical decisions (Elbe and Brand, 2016) and creating a sense of fair play and 
morality (Barkoukis et al., 2016) make sense in the context of competitive sport, but seem less 
important outside of this environment. It should also be noted that despite the broad search 
terms applied in this review very little evidence on IPEDs other than AS was identified, 
indicating that research on approaches to tackle issues relating to misuse of drugs used alone 
or alongside AS such as melanotan and fat burning drugs is lacking.  
It was intended to examine intervention effectiveness in the context of BCTs and theory applied. 
While some BCTs appeared to be associated with more effective interventions, interpretation 
of these findings was often made difficult by ambiguous or brief descriptions of intervention 
content and components. A limitation of this review may be the application of recent tools to 
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identify BCTs and theory application, as it is recognised that studies published before new 
guidance and tools were available may be less likely to meet these standards. However, use of 
these tools enabled the examination of studies in a consistent manner and identification of 
strengths and weaknesses of the evidence base. It is likely that additional BCTs were applied 
in these interventions that could not be identified with sufficient confidence. Interventions that 
appeared more promising typically included higher numbers of BCTs and multiple intervention 
functions. Establishing norms regarding others’ perceptions of AS use, a concept further 
supported by mediation analyses of ATHENA and ATLAS interventions (Ranby et al., 2009; 
MacKinnon et al., 2001), and including an element of skills training, either weight training or 
imparting resistance skills alongside educational components, may be promising approaches.  
The interventions in this review were primarily educational and based on the idea that people 
will make rational decisions, and therefore that increasing motivation to avoid AS and pursue 
healthy alternatives will reduce use. However, decisions about health and behaviour are not 
always rational and based upon a simple assessment of costs and benefits. To inform future 
interventions, research is required to increase understanding on which factors influence AS 
decision-making and increase risk amongst different populations. For example, although 
limited through its cross-sectional design, a community-based intervention included in this 
review sought to establish norms around AS use and appearance, and was associated with small 
reductions in AS use (Nilsson et al., 2004). If identified that social norms and peer expectations 
are significant factors influencing AS use then future interventions should test how to target 
these constructs. 
Interventions may be informed by interventions targeting body image disturbance and eating 
disorders, which have frequently been based upon changing perceptions about media images, 
critiquing appearance ideals and increasing self-esteem (Alleva et al., 2015; Bailey et al., 2014). 
There is clear overlap with these concepts and strategies described within this review, and AS 
use is commonly discussed alongside body image and eating disorders (Rohman, 2009; 
Olivardia et al., 2004). With patterns of dependence amongst long-term AS users (Kanayama 
et al., 2009), and similarities between disorders such as muscle dysmorphia and behavioural 
addictions (Foster et al., 2015), approaches may also be informed by the evidence on preventing 
addictive behaviours. The transferability of messages from these fields is worthy of further 
exploration, and may be more appropriate to consider than evidence from attempts to reduce 
doping activities amongst athletes.   
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The lack of evidence about intervention impact upon AS use limits the findings of this review. 
This outcome was measured in five studies only, and intervention effects were small. Baseline 
levels of use were low, limiting the potential to demonstrate effectiveness with short-term 
follow-up measures. Additionally, while school years may be associated with onset of AS for 
a minority of users, initiation has more frequently been reported from 20-30 years of age (Pope 
et al., 2014a; Sagoe et al., 2014a), an age that interventions have very rarely targeted. As young 
people move from school into new environments, they are likely to be exposed to different 
opportunities, social expectations and pressures, which may affect motivation and factors that 
influence their decisions. It is feasible that interventions associated with effects on potential 
mediators may have positive impacts on future AS use, but further testing of key theoretical 
concepts in experimental situations is required.  
The weakness of the evidence base is not just a reflection of the scarcity of evaluated 
interventions, but of their reporting. Since the publication of the earliest articles included within 
this review, a range of tools, guidance and checklists have been developed to support the 
development, delivery and reporting of interventions (Michie et al., 2013; Hoffmann et al., 
2014; Des Jarlais et al., 2004). The development, delivery and evaluation of future 
interventions should be grounded in theory (Craig et al., 2008; Glanz and Bishop, 2010) and 
reporting should enable the reader to identify how and why the interventions were designed, 
and which mediating variables were targeted. Additionally, reporting of intervention fidelity, 
participant understanding of interventions and detail regarding comparison conditions was 
largely missing in the studies included in this review. Intervention fidelity can act as a 
moderating factor on why interventions are effective or ineffective and should be evaluated 
and reported (Bartholomew and Mullen, 2011; Gearing et al., 2011). It is recognised that 
authors are restricted in the amount of information they can provide in articles, but can make 
supporting information such as protocols and manuals freely accessible elsewhere (Abraham 
et al., 2014). This will increase transparency, understanding of what has been implemented and 
replicability. Only through the accumulation of replicable and well-reported interventions will 
a meaningful and rich evidence base emerge.  
Conclusion  
This review highlights that despite the increase in research around AS and other IPEDs over 
the past three decades, and substantial increase in use of these substances outside of 
professional sport, there is little evidence on how to reduce use. What evidence there is comes 
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predominantly from a set of stand-alone interventions delivered to school-based athletes that 
focus on a wide range of mediating factors, and there is a clear need to respond to the very 
different issues of the use of these drugs outside of sporting environments and in adult 
populations. Increasing understanding on factors that influence decision-making, and the 
transferability of evidence from other relevant fields, will inform strategies to tackle AS use. 
A more consistent and rigorous approach to the development and reporting of interventions, 
with reference to the tools and guidance developed over the past decade in the field of 
behaviour change science, is required to establish the evidence base in this area.  
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Table 1: Summary of included articles 
Intervention description 
(Control group) 
Citation(s) 
(Country) 
Participants and 
setting 
Design 
(sample 
size) 
Quality 
rating 
IPED Outcomes (follow 
up length) 
Summary of results 
Anti-doping culture 
promotion 
(General health education) 
Barkoukis et al., 
2016 
(Greece) 
Male and female 
adolescents at school 
RCT  
(218) 
Moderate 
Doping attitudes; 
Perceived prevalence of 
doping in professional 
athletes 
(Post-intervention) 
No intervention impact on doping attitudes, or perceived 
prevalence of doping amongst athletes in Greece. 
 
Online doping ethical 
decision making training 
(Usual education; no 
intervention)  
Elbe & Brandt, 
2016 
(Germany) 
Male adolescent 
athletes at school  
 
CBA  
(69) 
 
Weak 
Doping attitudes 
(Post-intervention) 
Slight increase in undesirable attitudes towards doping 
following ethical training, although attitudes remained 
negative towards doping.  
ATHENA: health promotion 
intervention 
(Information pamphlet) 
Elliot et al., 
2004, 2006, 
2008; Ranby  et 
al., 2009 
(USA) 
Female adolescent 
athletes at school  
 
RCT  
(928) 
Moderate 
Use of body shaping 
substances; AS 
intentions, knowledge & 
norms; Body image 
(Post-intervention, 2 
years) 
At short-term evaluation ATHENA had a positive effect on 
initiation of body shaping substances, but there was no long-
term effect. Intentions to use AS and creatine were reduced 
compared to the control group at long-term evaluation. Short-
term knowledge of AS effects increased compared to 
controls, but perceptions of peers’ use of IPEDs and coach 
and peer attitudes to body weight were mixed across 8 
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measures. At long-term evaluation ATHENA participants 
favoured a heavier body shape compared to controls. 
Brief educational intervention 
with handout 
(Handout only; no 
intervention) 
Goldberg et al,, 
1990 
(USA) 
Male adolescent 
athletes at school  
RCT  
(190) 
Weak 
AS attitudes & 
knowledge 
(2 weeks) 
Attitudes towards AS improved slightly in all groups. 
Knowledge of AS adverse effects increased compared to 
handout only controls on 3/13 measures and to no 
intervention controls on 6/13 measures.  
Brief educational intervention 
with handout; Fear based 
education intervention with 
handout 
(No intervention) 
Goldberg et al., 
1991 
(USA) 
Male adolescent 
athletes at school  
RCT 
(192) 
Weak 
AS attitudes, belief in 
negative consequences of 
AS use 
(2 weeks) 
No impact of the balanced or fear based education on 
attitudes towards personal AS use across 7 measures. Greater 
belief in adverse effects for participants who received the 
balanced intervention compared to fear based education or 
control groups. No change in belief in adverse effects 
amongst the fear based education group. 
ATLAS (Pilot): steroid 
education and nutrition and 
strength training 
(No intervention)  
Goldberg et al., 
1996a 
(USA) 
Male adolescent 
athletes at school  
CBA  
(120) 
Weak 
AS intentions & 
attitudes; Ability to resist 
AS offers 
(Post-intervention) 
Compared to controls intention to use AS was reduced 
slightly on 2 measures. Impact on attitudes and beliefs about 
AS and AS norms were mixed across measures and ability to 
resist drugs did not change. Perception of body image and 
knowledge about AS effects and alternatives to AS use were 
improved compared to controls. 
ATLAS: steroid education 
and nutrition and strength 
training 
Goldberg et al., 
1996b; 2000; 
Male adolescent 
athletes at school  
RCT 
(3,207) 
Strong 
Use of AS; AS attitudes, 
intentions, knowledge & 
There were fewer new incidences of AS use and lower 
intentions to use amongst ATLAS participants compared to 
controls at end of season and 1 year follow up. Attitudes and 
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(Information pamphlet) Mackinnon 
2001 
(USA) 
norms; body image; 
ability to resist AS offers 
(Post-intervention, 1 
year) 
knowledge regarding AS favoured ATLAS participants at 
both times. Impacts on normative beliefs and perceptions 
about others’ AS attitudes were mixed. Short-term benefits 
for drug resistance skills were not maintained at 1-year 
evaluation. 
SATURN: random drug 
testing programme 
(No intervention)  
Goldberg et al., 
2003 
(Pilot) 
(USA) 
Male adolescent 
athletes at school  
 
CBA 
(276) 
Weak 
Ergogenic drug use 
(including AS); drug 
attitudes & norms 
(Post-intervention) 
 
There was no effect on initiation of ergogenic drugs but there 
was a small reduction in past month use in both groups. 
SATURN participants were more likely to have undesirable 
perceptions of others’ drug use and attitudes, beliefs about 
drug consequences and drug testing and a greater desire to 
take risks. 
Goldberg et al., 
2007 (Full 
study) 
(USA) 
Male adolescent 
athletes at school  
RCT 
(1,396) 
Moderate 
Drug use (including AS), 
drug attitudes & norms 
(Post-intervention) 
There was no impact on past month drug use, but past year 
use was lower for SATURN participants on 2 of 4 time 
points. SATURN participants were more likely to have 
undesirable perceptions of others’ attitudes to drug use and 
drug testing, and a greater desire to take risks than controls. 
Anabolic steroid education 
(No intervention) 
Jalilian et al., 
2008 
(Iran) 
Male adolescent and 
adult community gym 
members 
RCT 
(120) 
Moderate 
Use of AS; AS 
intentions, attitudes, 
norms & knowledge 
(Post-intervention) 
AS use was reduced in both groups, but by a greater amount 
amongst the intervention group. 
Intentions to use AS were reduced in the intervention group 
only. Attitudes and knowledge about AS changed in a 
favourable direction in both groups, but changes were greater 
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in the intervention group. There was no impact on subjective 
norms. 
Health education intervention  
(No intervention) 
Laure & Lecerf, 
1999 
(France) 
Male and female 
adolescent athletes at 
school  
CBA 
(287) 
Weak 
Attitudes & beliefs about 
doping 
(3 months) 
Impacts were mixed with the intervention having a positive 
impact on some of the 35 measures amongst the intervention 
group and no impact on other measures.  
Health education intervention  
(Information provision; no 
intervention) 
Laure & Lecerf, 
2002 
(France) 
Male and female 
adolescent athletes at 
school  
CBA 
(379) 
Moderate 
Attitudes & beliefs about 
doping 
(3 months) 
Across 35 measures education intervention participants had 
reduced risk factors and increased protective factors for 
doping compared to information only and no intervention 
controls. There was no impact of the information only 
intervention compared to controls.  
Appearance and social norms 
focussed program  
(Not applicable) 
Nilsson et al., 
2001, 2004 
(Sweden) 
Male adolescents in 
the community 
CCS  
(345) 
Weak 
Use of AS: tablets, 
injection  
(Post-intervention) 
The proportions of participants using injectable and oral AS 
were reduced in the community following the intervention for 
injectable AS (1.9% reduction) and oral AS (1.3% reduction) 
Hercules: anti-doping 
education alone or with 
strength training (No 
intervention) 
Sagoe et al., 
2016 
(Norway) 
Male and female 
adolescents at school 
 
RCT 
(202) 
Strong 
AS intentions & 
knowledge; doping 
attitudes 
Satisfaction with 
appearance; ability to 
resist AS offers 
(Post-intervention) 
Intentions to use AS increased slightly following the 
education & training intervention, but there were no 
significant differences compared to education alone or 
control groups. There was no intervention impact on attitudes 
towards doping, ability to reject AS offers or appearance 
satisfaction, but knowledge about AS and AS consequences 
increased following both education and training, and 
education alone, interventions.  
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Anabolic steroid education 
(Not reported)  
Trenhaile et al., 
1997 
(USA) 
Male pre-adolescent 
athletes at school 
 
RCT 
(35) 
Strong 
AS attitudes & 
knowledge;  
self esteem; peer 
resistance  
(Post-intervention) 
Attitudes and knowledge about AS were improved following 
the intervention and changed favourably compared with 
controls. No intervention impact reported on esteem or peer 
resistance. 
Drug education  
(No intervention) 
Tricker & 
Connolly 1996 
(USA) 
Male and female 
adolescent athletes at 
University 
CBA 
(635) 
Weak 
AS intentions & 
attitudes; drug 
knowledge 
(Post-intervention) 
Intervention participants had lower intentions to use AS on 
1/3 measures and more desirable attitudes about AS on 2/2 
measures than controls. No intervention impact on 
knowledge about performance enhancing drugs or other 
substances. 
Anti-doping activities + 
curriculum  
(Curriculum only) 
Wippert & 
Fleißer 2016  
(Germany) 
Male adolescent 
athletes at school 
 
CS 
(213) 
Weak 
Doping knowledge 
(Up to 2 years) 
Knowledge about doping was greater amongst those who 
received the anti-doping activities in addition to regular 
curriculum  
RCT=Randomised controlled trial. CCS = Cohort cross sectional study. CS=Cross sectional study. CBA=Controlled before and after study. AS=Anabolic steroids.  
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Table 2: Behaviour change techniques applied 
Study 
Goal setting 
(behaviour) 
Self-
monitoring 
Instruction 
on how to 
perform the 
behaviour 
Information 
about health 
consequences 
Salience of 
consequences 
Information 
about social & 
environmental 
consequences 
Demonstration 
of behaviour 
Information 
about 
others’ 
approval 
Behavioural 
practice/ 
rehearsal 
Behaviour 
substitution 
Credible 
source 
Restructuring 
the physical 
environment 
Framing/ 
reframing 
Punishment 
1    √  √    √     
2             √  
3 √ √ √   √  √ √    √  
4    √           
5    √ √ √         
6 √  √ √  √ √  √   √   
7              √ 
8   √ √      √ √    
9      √ √        
10    √ √ √  √       
11   √ √  √   √      
12 √  √ √           
13      √    √ √    
14      √     √    
1=Barkoukis et al. (2016). 2=Elbe & Brand (2016). 3=Elliot et al. (2004). 4=Goldberg et al. (1990). 5=Goldberg et al. (1991). 6=Goldberg et al. (1996a; 1996b). 7=Goldberg 
et al. (2003; 2007). 8=Jalilian et al. (2011). 9=Laure & Lecerf (1999; 2002). 10=Nilsson et al. (2001; 2004). 11=Sagoe et al. (2016).  12=Trenhaile et al.  (1997). 13=Tricker 
& Connolly (1996). 14=Wippert & Fleißer (2016). 
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Appendix 1  The behaviour change function(s) of interventions 
Persuasion (n=7) Training (n=5)
Environmental 
restructuring (n=1)
Coercion (n=1)
Elbe, 2016
Barkoukis, 2016
Goldberg, 1990
Tricker, 1996
Wippert, 2016
Goldberg, 1991
Laure, 1999; 2002
Nilsson, 2004 Elliot, 2004 Goldberg, 1996a; 1996b
Goldberg 2003; 2007
Jalilian, 2011
Sagoe, 2016
Trenhaile, 1997
Education (n=12)
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Appendix 2  Changes in IPED use 
Citation(s) 
Study design 
Outcome (follow up 
time) 
Sample size Measure Pre-intervention Post-
intervention  
Summary 
I  C   I C I  C  
Elliot et al., 2004; Ranby et 
al., 2009 (ATHENA) 
RCT 
Initiation of body shaping 
drug use (post-season) 
457 471  Not reported Not reported Lower initiation of body shaping substances, including 
AS,  amongst ATHENA students, risk ratio =1.55 
(1.03, 1.21) 
Steroid and creatine use 
(2 years) 
406 411 Mean 
(SD) 
Not 
reported 
Not 
reported 
0.02 
(0.2) 
0.02 
(0.2) 
No impact on steroid or creatine use compared to 
controls, beta coefficient =0.001. 
Goldberg et al., 1996b; 
2000 (ATLAS) 
RCT 
Lifetime AS use (post-
season) 
1,145 1,317 % 1.0 1.5 1.5 2.5 Lifetime use of AS increased at a lower rate amongst 
ATLAS students following the intervention compared 
to control at both time points (Effect size not 
calculable). 
Lifetime AS use (post-
season) 
591 700 % 1.0 1.5 1.7 3.4 
Goldberg et al., 2003 
(SATURN) 
CBA 
New use ergogenic drugs 
(post-season) 
62 95 Mean 
(SD) 
0.00 0.00 0.11 
(0.31) 
0.10 
(0.30) 
The SATURN intervention had no effect on initiation 
of ergogenic drugs, Cohen’s d= 0.03 (-0.28, 0.36). 
Past month use ergogenic 
drugs (post-season) 
Mean 
(SD) 
0.05 
(0.22) 
0.05 
(0.22) 
0.03 
(0.18) 
0.11 
(0.32) 
Reduction in past month use of ergogenic drugs 
amongst SATURN participants Cohen’s d= -0.30 (-
0.62, -0.02). 
Jalilian et al., 2011 (AS 
education intervention) 
RCT 
AS use (2 months) 60 60 % 18.3 21.7 10.0 18.3 Use of AS was reduced in both groups, but there was a 
greater increase amongst those who received the 
intervention, Cohen’s d= -0.39; CI -0.98, 0.20. 
Nilsson et al., 2001; 2004 
(appearance norms-based 
intervention) 
CCS 
Oral AS use (2 years)1 450 332 % 6.6 4.7 The proportions of participants using injectable and 
oral AS were reduced in the community following the 
intervention (Effect size not calculable). Injectable AS use (2 
years)1 
450 340 % 2.4 1.1 
 
RCT=randomised controlled trial. CBA=controlled before and after study. CCS=cross sectional cohort study. I=intervention group. C=control group. AS=anabolic steroids. 
RCT=randomised controlled trial. CCS=cohort cross sectional. CS=cross sectional. SD=standard deviation. NR=not reported in article. d=cohen’s d. RR=risk ratio. 1Data is 
reported separately for 16 and 17 year olds in the cited articles and combined here  
28 
 
ONLINE SUPPLEMENTARY MATERIALS 
Search strategy for searching in Medline (Ebsco) 
Search Search Terms # articles 
S1 MM “Doping in sports” OR MM "Anabolic Agents" 6,889 
S2 (TI (anabolic n4 steroid*) OR PED OR PEDs OR IPED* OR PIED* OR 
(performance N1 enhancing) OR (enhance performance) OR (performance N1 
enhancement) OR (muscle enhancing) OR (muscle N1 enhancement) OR 
(enhance muscle*) OR (muscular N1 enhancement)) OR (AB (anabolic n4 
steroid*) OR PED OR PEDs OR IPED* OR PIED* OR (performance N1 enhancing) 
OR (enhance performance) OR (performance N1 enhancement) OR (muscle 
enhancing) OR (muscle N1 enhancement) OR (enhance muscle*) OR (muscular 
N1 enhancement)) 
37,961 
S3 
S1 OR S2 41,747 
S4 MH “Schools” OR MH "Sports+" OR MH "Youth Sports" OR MH "Athletes" OR 
MH "Prisons" OR MH "Weight Lifting" OR MH "Resistance Training"  
187,335 
S5 TI (school* OR gym* OR athlet* OR sport* OR fitness OR prison* OR offender* 
OR jail* OR (detention N1 (center OR centre))  OR (youth* n2 (club* OR 
centre* OR center* OR group*)) OR bodybuilder* OR (body N1 builder*) OR 
bodybuilding OR (body N1 building) OR weightlift* OR (weight* N2 train*) OR 
(strength* N2 train*) OR (resistance N2 train*) OR (power N2 lift*) OR gay OR 
homosexual OR LGBT)  
158,107 
S6 AB (school* OR gym* OR athlet* OR sport* OR fitness OR prison* OR offender* 
OR jail* OR (detention N1 (center OR centre))  OR (youth* n2 (club* OR 
centre* OR center* OR group*)) OR bodybuilder* OR (body N1 builder*) OR 
bodybuilding OR (body N1 building) OR weightlift* OR (weight* N2 train*) OR 
(strength* N2 train*) OR (resistance N2 train*) OR (power N2 lift*) OR gay OR 
homosexual OR LGBT)  
314,122 
S7 (TI (excess* OR addict* OR dependen*) N2 (exercise OR train* OR (physical N1 
activity)) OR (musc* N1 dysmorph*)) OR (AB (excess* or addict* OR 
dependen*) N2 (exercise OR train* OR (physical N1 activity))) 
3,217 
S8 S4 OR S5 OR S6 OR S7 509,846 
S9 S3 AND S8 6,465 
S10 Limit: date of publication 1990-2016; Human 4,646 
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Results of study quality assessment 
Quality assessment of all studies included in the review was undertaken using the Effective 
Public Health Practice Project quality assessment tool. Further information on the tool is 
available at: http://www.ephpp.ca/tools.html. 
Citation Selection 
bias 
Study 
design 
Confou-
nders 
Blinding Data 
collection 
methods 
Withdrawal
& drop outs 
Global 
Rating 
Barkoukis et al, 2016 Moderate Moderate Weak Moderate Moderate Strong Moderate 
Elbe & Brand, 2016 Weak Moderate Weak Moderate Strong Strong Weak 
Elliot et al., 2004; 2006; 
2008; Ranby et al., 2009 
Moderate Strong Strong Moderate Strong Weak Moderate 
Goldberg et al., 1990 Weak Moderate Weak Moderate Weak Weak Weak 
Goldberg et al., 1991 Weak Moderate Weak Moderate Weak Weak Weak 
Goldberg et al., 1996a Weak Weak Strong Moderate Strong Weak Weak 
Goldberg, 1996b; 2000; 
MacKinnon 2001 
Moderate Moderate Strong Moderate Strong Moderate Strong 
Goldberg et al., 2003 Weak Weak Strong Moderate Strong Weak Weak 
Goldberg et al., 2007 Moderate Moderate Strong Moderate Strong Weak Moderate 
Jalilian et al., 2008 Moderate Moderate Strong Moderate Strong Strong Moderate 
Laure & Lecerf, 1999 Moderate Weak Weak Moderate Weak Weak Weak 
Laure & Lecerf, 2002 Moderate Moderate Strong Moderate Strong Weak Moderate 
Nilsson et al., 2001; 2004 Strong Weak Weak Moderate Strong Moderate Weak 
Sagoe et al., 2016 Moderate Moderate Moderate Moderate Strong Moderate Strong 
Trenhaile et al., 1997 Moderate Moderate Strong Moderate Strong Strong Strong 
Tricker & Connolly, 1996 Weak Weak Strong Moderate Strong Weak Weak 
Wippert & Fleißer, 2016 Weak Weak Weak Moderate Weak Moderate Weak 
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Summary of intervention delivery  
Citation Intervention Provider Mode of delivery Duration Intensity Fidelity 
Barkoukis et al., 
2016 
Anti-doping culture 
promotion  
Physical education 
teachers 
Group Not reported 10 x 2 hour sessions Not reported 
Elbe & Brand, 
2016 
Ethical decision 
making training  
Online 
Individually accessed 
computer programme 
3 weeks (average) 6 sessions Not applicable 
Elliot et al., 2004, 
2006, 2008 
Ranby et al., 2009 
ATHENA Coach & peers Group Not reported 8 x 45 minute sessions High 
Goldberg et al., 
1990 
Brief educational 
intervention  
Not reported Group Single session 
1x 20 minutes plus Q&A 
session & handout 
Not reported 
Goldberg et al., 
1991 
Brief educational 
intervention 
Medical students Group Single session 
1x 20 minutes plus Q&A 
session & handout 
Not reported 
Brief fear-based 
intervention 
Goldberg et al., 
1996a; 1996b; 
2000 
MacKinnon et al., 
2001 
ATLAS 
Coach, peers & research 
staff 
Group 7 weeks  
1x 50 minute classroom 
session & 1 weight room 
session per week 
Not reported 
Goldberg et al., 
2003; 2007 
SATURN Not applicable Not applicable 1 year Not applicable Not applicable 
Jalilian et al., 
2008 
Anabolic steroid 
education  
Peers Group Not reported 
6 x 1 hour sessions; 1 x 3 
hour workshop 
Not reported 
Laure & Lecerf, 
1999 
Health education based 
intervention  
Research team (1999); 
Doctor & coach (2002) 
Group Single session 1 x 2 hour session Not reported 
Nilsson et al., 
2001; 2004 
Appearance and social 
norms focussed 
program  
Health workers Group; Media 2 years 
Exposure to the intervention 
throughout duration 
Not reported 
Sagoe et al., 2016 Hercules  Anti-doping Norway  Group 12 weeks 
4 x 90 minute education 
sessions; 12 x weight 
training sessions 
Not reported 
Trenhaile et al., 
1997 
Anabolic steroid 
education 
Not reported Group 2 weeks 6 x 30 minute sessions Not reported 
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Tricker & 
Connolly, 1996 
Drug education  
Public Health official & 
coach 
Group 10 weeks Not reported Not reported 
Wippert & 
Fleißer, 2016 
Anti-doping education 
National Anti-doping 
Association 
Group 2 x 1 day 
1 day information tour 
presence in school; 1 day 
seminar 
Not reported 
 
 
